PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC issued a reminder to PROCEPT BioRobotics investors regarding a lead plaintiff deadline in a securities class action lawsuit alleging undisclosed inventory issues. The complaint cites a stock decline of approximately 18% in February 2026 following an earnings report that revealed excess field inventory and a sequential drop in handpiece sales.
Key figures
- Q3 handpiece sales
- 13225
- Q4 handpiece sales
- 9400
- Excess inventory units
- more than 10,000
- Sequential decline pct
- nearly 30%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.